Nephrectomy

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy

Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial

Post-immunotherapy Nephrectomy for Metastatic Kidney Cancer After Complete or Major Response to Systemic Therapy

Long-term Risk of Cardiovascular Disease in Living Kidney Donors

Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma

Scrotal Surgery After Laparoscopic Donor Nephrectomy

Fracture Risk in Living Kidney Donors

Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)

Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer

Clinical Trial to Assess the Importance of Nephrectomy

Cardiovascular Remodeling in Living Kidney Donors With Reduced Glomerular Filtration Rate

Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer

NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma

The Incidence of Pulmonary Embolism During Nephrectomy

A Prospective UK Multicentre Study of Kidney Donors

Enzalutamide Before Surgery in Treating Patients With Kidney Cancer

Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy

Phase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas

Nivolumab in Treating Patients With High-Risk Kidney Cancer Before Surgery